And one was on a placebo!
http://www.bloomberg.com/apps/news?p...I&refer=europe
I wonder if the odds are consistent with incidence of MS in the general obese diabetic population or if it was much higher in this trial, if the 2 on the drug actually developed MS
because of the drug.